Procarbazine, lomustine, and vincristine (PCV) plus radiotherapy (RT) “may be an especially effective treatment” for a subset of patients with 1p/19q co-deleted anaplastic oligodendrogliomas, both pure (AO) and mixed (anaplastic oligoastrocytoma [AOA]).
Cell Therapeutics announced that Opaxio (paclitaxel poliglumex) has been granted orphan drug designation by the FDA for the treatment of glioblastoma multiforme (GBM), a malignant brain cancer.
Cell phone use has been linked to cancer in the past, but how valid were those studies and what does current research say?
Strongest associations seen for oligodendroglial tumors, gliomas with IDH1/IDH2 mutations.
Gene expression patterns in MYCN-nonamplified metastatic neuroblastoma (NBL-NA) and tumor-associated macrophages are associated with metastasis risk and might explain age-associated differences in NBL-NA patient prognosis.
Glioblastoma patients presenting with more than one tumor have significantly shorter survival times than those with lone tumors.
A vaccine against targeted antigens prolongs survival in glioblastoma patients, according to a team of researchers.
Modification of a tumor suppressor protein in glioblastomas leads to shortened survival times and drug resistance.
Children of U.S.-born Latinas have a high risk of developing retinoblastoma.
When the interval between testing positive for total IgE and diagnosis of glioma was at least 20 years, there was a decreased risk of developing the disease.
